Related references
Note: Only part of the references are listed.New anti-cancer chemicals Ertredin and its derivatives, regulate oxidative phosphorylation and glycolysis and suppress sphere formation in vitro and tumor growth in EGFRvIII-transformed cells
Sonoko Atsumi et al.
BMC CANCER (2016)
Stability and Bioavailability of Lentztrehaloses A, B, and C as Replacements for Trehalose
Shun-ichi Wada et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Small molecules modulating tumor-stromal cell interactions: new candidates for anti-tumor drugs
Manabu Kawada
JOURNAL OF ANTIBIOTICS (2016)
New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice
Shuichi Sakamoto et al.
CANCER SCIENCE (2015)
Synthesis and Determination of Absolute Configuration of Lentztrehalose A
Ming Zhang et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2015)
Novel autophagy inducers lentztrehaloses A, B and C
Shun-ichi Wada et al.
JOURNAL OF ANTIBIOTICS (2015)
Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
Jessica M. Foley et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Can Trehalose Prevent Neurodegeneration? Insights from Experimental Studies
Enzo Emanuele
CURRENT DRUG TARGETS (2014)
Structure and biological properties of lentztrehalose: a novel trehalose analog
Shun-ichi Wada et al.
JOURNAL OF ANTIBIOTICS (2014)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
Hui K. Gan et al.
FEBS JOURNAL (2013)
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp ML96-86F2
Manabu Kawada et al.
JOURNAL OF ANTIBIOTICS (2013)
Synthesis of Intervenolin, an Antitumor Natural Quino lone with Unusual Substituents
Hikaru Abe et al.
ORGANIC LETTERS (2013)
Overcoming anoikis - pathways to anchorage-independent growth in cancer
Marta C. Guadamillas et al.
JOURNAL OF CELL SCIENCE (2011)
Trehalose: Current Use and Future Applications
Satoshi Ohtake et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Novel strategies for the treatment of small-cell lung carcinoma
William N. William et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716
Manabu Kawada et al.
JOURNAL OF ANTIBIOTICS (2010)
Targeting anoikis resistance in prostate cancer metastasis
Shinichi Sakamoto et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions
Manabu Kawada et al.
CANCER SCIENCE (2009)
New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells
Manabu Kawada et al.
JOURNAL OF ANTIBIOTICS (2009)
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
GA Smolen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy
MW Pedersen et al.
ANNALS OF ONCOLOGY (2001)
Share Paper
